Richard L. Wynn, PhD, is professor emeritus of pharmacology in the Department of Neural and Pain Sciences at the University of Maryland School of Dentistry.

He is a nationally recognized speaker, author, columnist, and consultant on dental drug therapeutics and drug information for the dental professional. He is the lead author of the most recognized chairside dental drug reference book, Drug Information Handbook for Dentistry, now in its 29th edition.

Dr. Wynn keeps the dental profession informed about current issues relative to drugs in dentistry, including new therapeutic agents, new drug interactions, and newly reported adverse reactions in dental patients. He researches the literature daily for new reports of interest to the profession.  

The first part of Program 4 focuses on the pharmacokinetic aspects of oral drug administration, including absorption, distribution, metabolism, and excretion. This section highlights critical concepts such as first-pass metabolism and the role of cytochrome P450 enzymes.

Upon completion of Program Four, Part 1, participants will be able to:

• Identify a primary goal of oral sedation.
• List three advantages of oral premedication.
• List three disadvantages of oral premedication.
• Define first-pass metabolism and its implications.
• Differentiate between Phase I and Phase II drug metabolism.
• Identify the most prevalent CYP enzyme family.
• Define drug half-life and its clinical significance.
• Explain the concept of patient variability in drug response.

Upon completion of the online course, participants are required to pass an online post-course assessment with a minimum grade of 75%.

Once the online course has been accessed, no refunds will be provided.

Cancellation and Refund Policies